These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3838719)
21. [Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease]. Kanaev SV; Gershanovich ML; Malinin AP; Kholin AV Med Radiol (Mosk); 1987 May; 32(5):16-21. PubMed ID: 3586917 [TBL] [Abstract][Full Text] [Related]
22. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease. Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778 [No Abstract] [Full Text] [Related]
23. Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation. Koza I; Bohunický L; Svancárová L; Mardiak J; Gyárfás J; Cerný V Neoplasma; 1989; 36(6):709-18. PubMed ID: 2615874 [TBL] [Abstract][Full Text] [Related]
24. [Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride]. Kozai Y; Ohyama T; Kodo H; Tomori G Gan To Kagaku Ryoho; 1992 Dec; 19(14):2407-9. PubMed ID: 1281397 [TBL] [Abstract][Full Text] [Related]
27. A new combination chemotherapy for recurrent Hodgkin's lymphoma. Rahim MA; Sarma SK; Ahmed Q Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):63-7. PubMed ID: 6897860 [TBL] [Abstract][Full Text] [Related]
28. [Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)]. Błasińska-Morawiec M; Płuzańska A; Krykowski E; Robak T; Mrówka I Pol Arch Med Wewn; 1991 Oct; 86(4):274-80. PubMed ID: 1813880 [TBL] [Abstract][Full Text] [Related]
30. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results. Hancock BW; Vaughan Hudson G; Vaughan Hudson B; Haybittle JL; Bennett MH; MacLennan KA; Jelliffe AM Br J Cancer; 1991 Apr; 63(4):579-82. PubMed ID: 2021542 [TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycin. Pillai GN; Hagemeister FB; Velasquez WS; Sullivan JA; Johnston DA; Butler JJ; Shullenberger CC Cancer; 1985 Feb; 55(4):691-7. PubMed ID: 2578302 [TBL] [Abstract][Full Text] [Related]
32. Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation. Hancock BW Radiother Oncol; 1986 Nov; 7(3):215-21. PubMed ID: 3544084 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of Hodgkin's disease by chemotherapy with MOPP alone. Long-term results]. Colonna P; Andrieu JM; Kubisz P; Malou M; Zouaoui Z; Abad MT; Touhami M; Faid L Presse Med; 1986 Mar; 15(13):599-602. PubMed ID: 2939416 [TBL] [Abstract][Full Text] [Related]
34. Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment. Coleman M; Friedlander RJ Cancer Invest; 1988; 6(2):237-9. PubMed ID: 3288299 [TBL] [Abstract][Full Text] [Related]
35. A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy. Carde P; MacKintosh FR; Rosenberg SA J Clin Oncol; 1983 Feb; 1(2):146-53. PubMed ID: 6689425 [TBL] [Abstract][Full Text] [Related]
36. Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-up. Olver IN; Wolf MM; Cruickshank D; Worotniuk V; Ding JC; Cooper IA; Matthews JP Cancer; 1988 Jul; 62(2):233-9. PubMed ID: 3383124 [TBL] [Abstract][Full Text] [Related]
37. Reversible mechlorethamine-associated hearing loss in a patient with Hodgkin's disease. Segal GM; Duckert LG Cancer; 1986 Mar; 57(6):1089-91. PubMed ID: 3753658 [TBL] [Abstract][Full Text] [Related]
38. The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease. Delmez JA; Safdar SH; Kissane JM Am J Kidney Dis; 1994 May; 23(5):743-6. PubMed ID: 8172220 [TBL] [Abstract][Full Text] [Related]
39. MOPP after two decades. Longo DL; Young RC; Duffey PL; Hubbard SM; DeVita VT J Clin Oncol; 1987 Feb; 5(2):320-1. PubMed ID: 3806177 [No Abstract] [Full Text] [Related]
40. Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up. Hallahan DE; Griem ML; Griem SF; Medenica M; Soltani K; Lorincz AL; Baron JM J Clin Oncol; 1988 Jul; 6(7):1177-83. PubMed ID: 3392562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]